'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
GENNEX LABORATORIES LTD.
GENNEX (BSE 531739) · ISIN INE509C01026 · Pharmaceuticals · Est. 1990 · listed 1996 · website
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹218.12 cr | ₹22.82 cr | ₹273.82 cr |
| 30 Sep 2025 standalone | ₹210.62 cr | ₹22.22 cr | ₹266.13 cr |
| 31 Mar 2025 standalone | ₹184.8 cr | ₹1.24 cr | ₹218.38 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 23.63% | — | 0.00% | 76.37% |
Latest filings
- In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time, please find enclosed herewith voting results of the 41st eAGM of the Company held on September .... 1 October 2026 · BSE
- Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of 41st eAGM of the Company held on Wednesday, September 30, 2026 through .... 30 September 2026 · BSE
- Annual Report FY2025-26 (New) 8 September 2026 · BSE
- 1. Draft Directors''/ Board Report for the Financial Year March 31, 2026; 2. The 41st Annual General Meeting of the Company to be held on Wednesday, September 30, 2026 at 12:30 P.M. through .... 4 September 2026 · BSE
- In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Unaudited Standalone and Consolidated Financial Statement for the Quarter ended .... 14 August 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.